AgeX Therapeutics(AGE) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights HUNTSVILLE, November 12, 2024 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. ("Serina") (NYSE American: SER), a clinical-stage biotechnology company advancing its lead IND candidate SER-252 for advanced Parkinson's disease, enabled by its proprietary POZ Platform™ drug optimization technology, today announced its financial results for the third quarter ended September 30, 2024, along with key recent ...